The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...
Abbott recalls glucose sensors linked to 7 deaths and 860 serious injuries; FDA urges discontinuation of specific FreeStyle Libre 3 models.
The U.S. Food and Drug Administration (FDA) is issuing an Early Alert for specific glucose monitoring systems after Abbott ...
Our comprehensive review of the Noise Luna Ring Gen 2, including analysis of the battery life, tracking accuracy, design, and ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors ...
Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its transformative Omnipod 5 Automated Insulin ...
Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.
Medical device maker Abbott Laboratories has reported 860 serious injuries linked to the recall of some of its glucose monitoring sensors, the U.S. Food and Drug Administration said on Wednesday, ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
A pharmaceutical giant has issued a widespread product recall affecting 17 countries, including the UK. Abbott is recalling approximately three million blood glucose sensors, widely used by people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results